Cite
MLA Citation
David Palma et al.. “157: A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiotherapy (SABR) Plus Surgery in Operable Patients with Early Non-Small Cell Lung Cancer (Missile-NSCLC): Interim Safety Results.” Radiotherapy and oncology, vol. 120, n.d., pp. S58–. http://access.bl.uk/ark:/81055/vdc_100035844025.0x000012